Statement of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net income attributable to common shares	$ (71,259)	$ 6,180,010
Amortization (accretion) of investments	(3,195,015)	89,854
Realized investment (gains) losses, net	(2,221,888)	255,755
Unrealized trading gains included in income	1,412,630	(1,948,042)
Amortization of deferred policy acquisition costs	51,519	71,426
Amortization of cost of insurance acquired	923,261	993,548
Depreciation	1,048,126	974,374
Net income attributable to noncontrolling interest	(40,469)	622,950
Charges for mortality and administration of universal life and annuity products	(5,547,734)	(5,815,192)
Interest credited to account balances	3,915,979	3,990,800
Change in accrued investment income	371,310	361,479
Change in reinsurance receivables	1,748,548	1,711,615
Change in policy liabilities and accruals	(3,856,527)	(3,739,909)
Change in income taxes receivable/payable	(3,260,867)	1,530,805
Change in other assets and liabilities, net	2,358,592	3,512,369
Net cash used in operating activities	(6,363,794)	8,791,842
Cash flows from investing activities:
Fixed maturities available for sale	130,999,311	21,589,727
Equity securities available for sale	3,231,410	728,830
Trading securities	14,209,807	119,229,039
Mortgage loans	2,984,255	12,988,130
Discounted mortgage loans	10,288,755	17,622,637
Real estate	9,921,610	2,234,784
Policy loans	3,478,803	2,584,784
Short-term investments	0	700,000
Total proceeds from investments sold and matured	175,113,951	177,677,931
Cost of investments acquired:
Fixed maturities available for sale	(125,182,803)	(21,844,183)
Equity securities available for sale	(781,307)	(1,110,445)
Trading securities	(4,641,579)	(131,279,792)
Mortgage loans	(846)	(2,459,814)
Discounted mortgage loans	(10,378,446)	(34,075,757)
Real estate	(12,431,325)	(1,415,023)
Policy loans	(2,862,585)	(2,394,625)
Total cost of investments acquired	(156,278,891)	(194,579,639)
Purchase of property and equipment	204,475	72,291
Net cash provided by (used in) investing activities	18,630,585	(16,973,999)
Cash flows from financing activities:
Policyholder contract deposits	4,743,069	5,083,206
Policyholder contract withdrawals	(4,690,873)	(4,760,813)
Proceeds from notes payable/line of credit	5,613,000	0
Payments of principal on notes payable/line of credit	(3,958,284)	(4,536,333)
Purchase of treasury stock	(443,282)	(172,625)
Distributions to minority interests of consolidated subsidiaries	388,275	517,390
Net cash used in financing activities	875,355	(4,903,955)
Net increase (decrease) in cash and cash equivalents	13,142,146	(13,086,112)
Cash and cash equivalents at beginning of period	18,483,452	37,492,843
Cash and cash equivalents at end of period	$ 31,625,598	$ 24,406,731